Beta-Glucan Market Drivers, Restraints, Opportunities & Challenges

The market for beta-glucan market is estimated at USD 403.8 million in 2020; it is projected to grow at a CAGR of 7.6% to reach USD 628.3 million by 2026. The growing deamand for healthier alternatives that do not have any adverse effect on the body along with shifting consumer preference towards healthier ingredients will drive the market demand and growth of beta-glucan globally.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5191796

Driver: Growing health consciousness among consumers and increasing health expenditure.

With the shift in demand from processed to healthy food, functional, and superfoods, consumers have become more conscious of their health and maintain it proactively through healthy living. Consumers are more aware of the food ingredients and pay attention to nutrition labels and ingredients of the food products. This change in buying habits has resulted in higher demand for healthy foods and supplements and has attracted several manufacturers to offer new food products that are functional, not genetically modified, and sourced naturally. With the increasing consciousness and concern about health and wellness, demand for multifunctional beta-glucan is expected to increase in the coming years.

Manufacturers are also redesigning products and reducing cholesterol, sugar, fats (trans-fat and saturated), and sodium content of the food. They are switching from artificial ingredients and introducing products high in protein, fibers, and others that offer functional benefits. These developments have also resulted in the rise of per capita expenditure in major economies in North America and Europe, showing that people are relatively spending more on health & wellness as compared to the last few years.

Restraint: Inconsistency in regulatory norms governing beta-glucan

The beta-glucan market is governed by different regulatory bodies, which vary regionally. The legislation regarding the extraction, processing, formulation, and end-product manufacturing is different from country to country. Health claims also differ at the country level, thereby hindering the usage of beta-glucan in pharmaceuticals as well as food & beverages. The regulations also govern and monitor claims made by end-product manufacturers and labeling requirements. Europe, despite being the primary market for beta-glucan products, regulations related to health claims were harmonized in late 2007 under art.13 and art.14 – Regulation of January 19th, 2007. For health-related claims, only beta-glucan extracted from oats is eligible, as oats are one of the major sources of higher beta-glucan content compared to yeast and barley.

Opportunity: Emerging markets: New growth frontiers

Changing lifestyles, growing economy, and shift toward natural products are observed in developing economies, leading to the growth in demand for beta-glucan, not only in food, personal care, and pharmaceutical products but also in other industrial applications, such as animal feed and biofuel production. Developing countries such as China, India, and countries in the Middle East & Africa, in the coming years, are expected to experience a sharp upsurge in demand for beta-glucan extracted from different raw materials. This demand is attributed to be driven by an increase in the consumption of healthy foods, nutraceuticals, and personal care products. In addition, these regions also provide cost optimization in terms of production, labor cost, and processing. High demand, coupled with a low cost of production, is a key feature that is expected to support beta-glucan manufacturers to enter into new geographies.

Challenge: High cost of beta-glucan extraction

The extraction of beta-glucan is dependent on factors, such as source, time, and technology. There are several methods of extraction available, which offer low-quality insoluble beta-glucan. For example, manufacturing of high-quality micronized beta-glucan of particle size 1–3 microns involves high costs apart as it include several processing steps to get the desired size of beta-glucan. This is done to make beta-glucan easily absorbable at the receptor site on immune cells. Also, expensive equipment is used to protect beta-glucan from re-aggregating, which can reduce the proper absorption of beta-glucan in the human body.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=5191796

Key players in this market include include major players such as Cargill Inc (US), Tate & Lyle Plc (UK), Kerry Group Plc (Ireland), Koninklijke DSM N.V. (Netherlands), Frutarom (Israel), Garuda International Inc (US), Ohly GmbH (Germany), Milliporesigma (US), Super Beta Glucan (US), Lesaffre Human Care (France), Kemin Industries (US), Angel Yeast Co Ltd (China), Biotec BetaGlucans AS (Norway), AIT Ingredients (France), Biorigin Zilor (Brazil), Ceapro Inc (Canada), Specialty Biotech Co Ltd (Thailand), Alltech Life Sciences (US).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.